Biohaven closes $200M public offering of 26.8M shares at $7.50/share

Biohaven Ltd.

Gross proceeds of approximately $200M from 26,833,334 common shares, including full exercise of underwriters' 3.5M share option.
Offering price set at $7.50 per share; underwriters led by J.P. Morgan and Goldman Sachs.
Shares issued under shelf registration statement filed October 2, 2023 (File No. 333-274822).
Net proceeds after underwriting discounts and expenses not disclosed; expected for general corporate purposes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.